收藏切换
Research advances on the NLRP3 inflammasome and its inhibitors in central nervous system diseases
收藏切换
Yi-ming LUO1, Jing-yuan SONG1, Zhong-jin YANG2, Ping SUN1, Pan-lin SHAO1, *, Wen-hui HU1, *
Acta Pharmaceutica Sinica | 2025, 60(11) : 3396 - 3407
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(11): 3396-3407
• Reviews •
Research advances on the NLRP3 inflammasome and its inhibitors in central nervous system diseases
Full
Yi-ming LUO1, Jing-yuan SONG1, Zhong-jin YANG2, Ping SUN1, Pan-lin SHAO1, *, Wen-hui HU1, *
Affiliations
  • 1School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China
  • 2School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China
Published: 2025-11-12 doi: 10.16438/j.0513-4870.2025-0370
Outline
收藏切换

Neuroinflammation plays a pivotal regulatory role in the onset and progression of various central nervous system diseases. As a key immune sensor, the NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome, upon activation, can exacerbate neuroinflammation, leading to neuronal injury and death, thereby accelerating the pathological processes of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Consequently, the NLRP3 inflammasome has emerged as an important therapeutic target for modulating neuroinflammation. In recent years, significant progress has been made in the development of NLRP3 inflammasome inhibitors. Numerous novel inhibitors have been identified that effectively reduce inflammatory responses and protect neurons from damage, demonstrating promising efficacy in animal models, particularly in improving cognitive and motor functions. This review will summarize the canonical activation mechanisms of the NLRP3 inflammasome, explore its pathogenic roles in central nervous system diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and depression, and provide an overview of recent advances in NLRP3-targeted drug development, aiming to offer new insights and strategies for the treatment of central nervous system diseases.

NLRP3 inflammasome  /  inhibitor  /  neuroinflammation  /  Alzheimer's disease  /  Parkinson's disease  /  multiple sclerosis
罗一鸣, 宋静远, 杨忠金, 孙平, 邵攀霖, 胡文辉. NLRP3炎症小体及其抑制剂在中枢神经系统疾病中的研究进展. 药学学报, 2025 , 60 (11) : 3396 -3407 . DOI: 10.16438/j.0513-4870.2025-0370
Yi-ming LUO, Jing-yuan SONG, Zhong-jin YANG, Ping SUN, Pan-lin SHAO, Wen-hui HU. Research advances on the NLRP3 inflammasome and its inhibitors in central nervous system diseases[J]. Acta Pharmaceutica Sinica, 2025 , 60 (11) : 3396 -3407 . DOI: 10.16438/j.0513-4870.2025-0370
Year 2025 volume 60 Issue 11
370
181
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0370
  • Receive Date:2025-04-02
  • Online Date:2026-09-20
  • Published:2025-11-12
Article Data
Affiliations
History
  • Received:2025-04-02
  • Revised:2025-07-19
Affiliations
    1School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China
    2School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0370
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT